Cis Bio Intl Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CIS BIO INTL SA
CIS BIO INTL SA has two approved drugs.
Drugs and US Patents for Cis Bio Intl Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cis Bio Intl Sa | NEO TECT KIT | technetium tc-99m depreotide | INJECTABLE;INJECTION | 021012-001 | Aug 3, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cis Bio Intl Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,443,815 | ⤷ Start Trial |
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,645,815 | ⤷ Start Trial |
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,508,020 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

